Vie K, Pons-Guiraud A, Dupuy P, Maibach H
Pierre-Fabre Research Institute, Toulouse, France.
Am J Contact Dermat. 2000 Sep;11(3):161-4. doi: 10.1053/ajcd.2000.7183.
This study evaluates the tolerance of preservative free sterile cleanser and sterile moisturizer in irritated and sensitive face skin.
An exploratory, open-label study using the cleanser and the moisturizer in combination was performed with 98 patients with a documented history of allergic contact dermatitis. The 2 products could each be used once or twice daily for 28 days. The assessment parameters at baseline and end of treatment (day 28) included the intensity of erythema, dryness/scaling by the investigator and subjective signs (burning, pruritus and stinging), according to a defined 4-point scale (absent to severe). In addition, a global assessment of the change from baseline and the overall tolerance of the products were performed by the investigator at the end of treatment.
Ninety-four patients were included for the efficacy analysis and 96 patients for the safety analysis. At baseline, a majority of patients expressed some degree of erythema (63%), and dryness/scaling (56%). Fewer patients experienced subjective signs at baseline (44%). At the end of treatment, the results showed a statistically significant improvement of all the objective signs of irritated skin (P = .0001, Mac Nemar test), as well as the subjective signs of sensitive skin (P < 0.02). This was confirmed by the overall investigator assessment, showing an excellent or good response in 90% of the patients. In the safety analysis, 1 patient developed contact allergy to 1 ingredient of the test products (carbomer), and 3 patients exacerbated their dermatitis.
Taken together, these results suggest that adequately formulated cosmetics might reduce both irritated and sensitive skin, with clinical improvement of dryness, erythema and stinging.
本研究评估无防腐剂无菌洁面乳和无菌保湿霜对受刺激和敏感面部皮肤的耐受性。
对98例有过敏性接触性皮炎病史记录的患者进行了一项探索性、开放标签的联合使用洁面乳和保湿霜的研究。这两种产品均可每天使用一次或两次,持续28天。根据定义的4分制量表(无至严重),基线和治疗结束时(第28天)的评估参数包括红斑强度、研究者评估的干燥/脱屑情况以及主观症状(灼痛、瘙痒和刺痛)。此外,研究者在治疗结束时对与基线相比的变化进行了整体评估,并评估了产品的总体耐受性。
94例患者纳入疗效分析,96例患者纳入安全性分析。基线时,大多数患者表现出一定程度的红斑(63%)和干燥/脱屑(56%)。基线时出现主观症状的患者较少(44%)。治疗结束时,结果显示受刺激皮肤的所有客观症状均有统计学显著改善(P = .0001,麦克尼马尔检验),敏感皮肤的主观症状也有改善(P < 0.02)。研究者的整体评估证实了这一点,显示90%的患者有优秀或良好的反应。在安全性分析中,1例患者对测试产品的1种成分(卡波姆)发生接触性过敏,3例患者的皮炎加重。
综上所述,这些结果表明,配方合理的化妆品可能会减轻受刺激和敏感的皮肤状况,使干燥、红斑和刺痛在临床上得到改善。